Sen. Rand Paul may have violated insider trading law by failing to disclose wife's COVID drug stock purchases

The Campaign Legal Center has filed a complaint with the Senate Ethics Committee targeting Republican Sen. Rand Paul of Kentucky, alleging that the senator may have failed to comply with an insider trading law. "This filing, coming over a year late and detailing the financial interest a senator held in a company producing an antiviral drug from the onset of a global pandemic, is a clear example of why greater STOCK Act enforcement is needed," said Kedric Payne, general counsel and senior director of ethics at Campaign Legal Center.

Read the full article here.